13F

Stock

Chemomab Therapeutics Ltd.

CMMB · held by 15 managers

Reported value

$551.9K

Holders

15

+3 new · −3 exited

Holders’ est. mark

−$23.9K

Price effect on 11 books still in the name

Largest holder

$125.6K

ADAR1 Capital Management, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ADAR1 Capital Management, LLC80K$125.6K−$6.4KCut−$6.4K
Citadel64.2K$100.8K−$5.13KCut−$70.5K
KESTRA PRIVATE WEALTH SERVICES, LLC61.7K$96.9K−$4.14KAdded$11.6K
Ikarian Capital, LLC51.8K$81.3K−$4.14KCut−$4.14K
XTX Topco Ltd18.6K$29.2K−$1.49KCut−$2.12K
RHUMBLINE ADVISERS18.4K$28.8K−$1.43KCut−$630
SmartHarvest Portfolios, LLC14.6K$22.9KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP13.5K$21.2KNew
BNP PARIBAS FINANCIAL MARKETS8.43K$13.2K−$650Cut−$179
Philadelphia Investment Partners, LLC8.2K$12.9KHeld
GAMMA Investing LLC7.58K$11.9K−$201Added$7.75K
MORGAN STANLEY4.58K$7.18K−$302Added$954
SBI Securities Co., Ltd.28$44−$2Added$1
Caitong International Asset Management Co., Ltd8$13New
UBS Group AG8$13−$0Cut−$3.7K

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.